<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7664781" created="27/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7664781</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="interleukin-2_promoter_activity" sem="Other"><term id="T2" lex="Interleukin-2_promoter" sem="DNA_domain_or_region">Interleukin-2 promoter</term> activity</term> in <term id="T3" lex="Epstein-Barr_virus-transformed_B_lymphocyte" sem="Cell_cultured"><term id="T4" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term>-transformed <term id="A1" sem="Cell_natural">B lymphocytes</term></term> is controlled by <term id="T5" lex="nuclear_factor-chi_B" sem="Protein_molecule">nuclear factor-chi B</term>.</sentence>
<event id="E1">
<type class="Regulation"/>
<theme idref="T1"/>
<cause idref="T5"/>
<clue>Interleukin-2 promoter activity <clueLoc>in Epstein-Barr virus-transformed B lymphocytes</clueLoc> is <clueType>controlled</clueType> <linkCause>by</linkCause> nuclear factor-chi B.</clue>
</event>
<event id="E2">
<type class="Biological_process"/>
<theme idref="A1"/>
<clue>Interleukin-2 promoter activity in Epstein-Barr virus-<clueType>transformed</clueType> B lymphocytes is controlled by nuclear factor-chi B.</clue>
</event>
<event id="E44">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T4"/>
<clue>Interleukin-2 promoter activity in Epstein-Barr virus-<clueType>transformed</clueType> B lymphocytes is controlled by nuclear factor-chi B.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The regulation of <term id="T6" lex="interleukin_(IL)-2_gene_expression" sem="Other"><term id="T7" lex="interleukin_(IL)-2_gene" sem="DNA_domain_or_region">interleukin (IL)-2 gene</term> expression</term> has been investigated mainly in <term id="T8" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term>, the predominant producers of <term id="T9" lex="IL-2" sem="Protein_molecule">IL-2</term>.</sentence>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T7"/>
<clue>The regulation of interleukin (IL)-2 gene <clueType>expression</clueType> has been investigated mainly in T lymphocytes, the predominant producers of IL-2.</clue>
</event>
<event KT="Investigation" Source="Other" id="E4" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E3"/>
<clue>The <clueType>regulation</clueType> <linkTheme>of</linkTheme> interleukin (IL)-2 gene expression <clueSource>has been</clueSource> <clueKT>investigated</clueKT> <clueSource>mainly</clueSource> <clueLoc>in T lymphocytes</clueLoc>, the predominant producers of IL-2.</clue>
</event>
<event KT="Other" id="E42">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>The regulation of interleukin (IL)-2 gene expression has been investigated mainly in <clueLoc>T lymphocytes</clueLoc>, the predominant <clueType>producers</clueType> <linkTheme>of</linkTheme> IL-2.</clue>
</event>
<sentence id="S3">However, <term id="T10" lex="B_cell" sem="Cell_natural">B cells</term> can also synthesize <term id="T11" lex="IL-2" sem="Protein_molecule">IL-2</term>.</sentence>
<event CL="L2" KT="Analysis" id="E5">
<type class="Gene_expression"/>
<theme idref="T11"/>
<clue>However, <clueLoc>B cells</clueLoc> <clueKT><clueCL>can</clueCL></clueKT> also <clueType>synthesize</clueType> IL-2.</clue>
</event>
<sentence id="S4">In the present study we analyzed the control of <term id="T12" lex="IL-2_promoter_activity" sem="Other"><term id="T13" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T14" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term> activity</term> in <term id="T15" lex="Epstein-Barr_virus_(EBV)-transformed_B_cell_clone" sem="Cell_cultured"><term id="T16" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> (<term id="T17" lex="EBV" sem="Virus">EBV</term>)-transformed <term id="A2" sem="Cell_cultured">B cell clones</term></term> which are capable of secreting <term id="T18" lex="IL-2" sem="Protein_molecule">IL-2</term> at a low level after stimulation with <term id="T19" lex="phorbol_12-myristate_13-acetate" sem="Organic_compound_other">phorbol 12-myristate 13-acetate</term> and the <term id="T20" lex="Ca2+_ionophore" sem="Organic_compound_other">Ca2+ ionophore</term> <term id="T21" lex="ionomycin" sem="Organic_compound_other">ionomycin</term>.</sentence>
<event KT="Other" id="E6">
<type class="Biological_process"/>
<theme idref="A2"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in Epstein-Barr virus (EBV)-<clueType>transformed</clueType> B cell clones which are capable of secreting IL-2 at a low level after stimulation with phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
</event>
<event KT="Other" id="E45">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T17"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in Epstein-Barr virus (EBV)-<clueType>transformed</clueType> B cell clones which are capable of secreting IL-2 at a low level after stimulation with phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
</event>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T12"/>
<clue>In the present study we <clueKT>analyzed</clueKT> the <clueType>control</clueType> <linkTheme>of</linkTheme> IL-2 promoter activity <clueLoc>in Epstein-Barr virus (EBV)-transformed B cell clones</clueLoc> which are capable of secreting IL-2 at a low level after stimulation with phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
</event>
<event KT="Method" id="E8">
<type class="Physiological_process"/>
<theme idref="T15"/>
<cause idref="T19"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in Epstein-Barr virus (EBV)-transformed B cell clones which are capable of secreting IL-2 at a low level after <clueType>stimulation</clueType> <linkCause>with</linkCause> phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
</event>
<event KT="Method" id="E9">
<type class="Physiological_process"/>
<theme idref="T15"/>
<cause idref="T21"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in Epstein-Barr virus (EBV)-transformed B cell clones which are capable of secreting IL-2 at a low level after <clueType>stimulation</clueType> <linkCause>with</linkCause> phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
</event>
<event KT="Other" id="E10">
<type class="Localization"/>
<theme idref="T18"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in <clueLoc>Epstein-Barr virus (EBV)-transformed B cell clones</clueLoc> which are capable of <clueType>secreting</clueType> IL-2 at a low level after stimulation with phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
</event>
<event KT="Fact" id="E40">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E8"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in Epstein-Barr virus (EBV)-transformed B cell clones which are capable of secreting IL-2 at a low level <linkCause>after</linkCause> stimulation with phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Fact" id="E41">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E9"/>
<clue>In the present study we analyzed the control of IL-2 promoter activity in Epstein-Barr virus (EBV)-transformed B cell clones which are capable of secreting IL-2 at a low level <linkCause>after</linkCause> stimulation with phorbol 12-myristate 13-acetate and the Ca2+ ionophore ionomycin.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S5"><term id="T22" lex="transient_transfection" sem="Other">Transient transfections</term> using <term id="A14" sem="DNA_domain_or_region"><term id="T23" lex="reporter_construct" sem="DNA_family_or_group">reporter constructs</term> with</term> multiples of transcription factor <term id="A15" sem="DNA_domain_or_region">binding sites from the <term id="T25" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T26" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term></term> [<term id="A21" sem="DNA_domain_or_region"><term id="T27" lex="distal_nuclear_factor_(NF)-AT" sem="Protein_molecule">distal nuclear factor (NF)-AT</term></term>, <term id="A22" sem="DNA_domain_or_region"><term id="T28" lex="proximal_NF-AT" sem="Protein_molecule">proximal NF-AT</term></term>, <term id="T29" lex="AP-1/Octamer" sem="Protein_molecule">AP-1/Octamer</term> (<term id="A23" sem="DNA_domain_or_region"><term id="T30" lex="UPS" sem="Protein_molecule">UPS</term></term>) or <term id="T31" lex="NF-chi_B" sem="Protein_molecule">NF-chi B</term> (<term id="A24" sem="DNA_domain_or_region"><term id="T32" lex="TCEd" sem="Protein_molecule">TCEd</term></term>) sites] were performed.</sentence>
<event KT="Method" id="E11">
<type class="Gene_expression"/>
<theme idref="A14" idref1="A21" idref2="A15"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event id="E49">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event KT="Method" id="E12">
<type class="Gene_expression"/>
<theme idref="A14" idref1="A22" idref2="A15"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event id="E50">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event KT="Method" id="E13">
<type class="Artificial_process"/>
<theme idref="A14" idref1="A23" idref2="A15"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event id="E51">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event KT="Method" id="E14">
<type class="Gene_expression"/>
<theme idref="A14" idref1="A24" idref2="A15"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<event id="E52">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<clue><clueType>Transient transfections</clueType> <linkTheme>using</linkTheme> <corefTheme>reporter constructs with multiples of transcription factor binding sites from the IL-2 promoter</corefTheme> [distal nuclear factor (NF)-AT, proximal NF-AT, AP-1/Octamer (UPS) or NF-chi B (TCEd) sites] were performed.</clue>
<comment>NER: T24 del &quot;transcription factor binding sites&quot;; TPS: A14 &amp; A15</comment></event>
<sentence id="S6">In <term id="T33" lex="EBV-transformed_B_clone" sem="Cell_cultured"><term id="A11" sem="Virus">EBV</term>-transformed <term id="A12" sem="Cell_cultured">B clones</term></term>, the <term id="T34" lex="chi_B_site" sem="DNA_domain_or_region">chi B site</term> exerted the <term id="T35" lex="strongest_inducible_activity" sem="Other">strongest inducible activity</term>; the <term id="T36" lex="NF-AT_binding_site" sem="DNA_domain_or_region">NF-AT binding sites</term> showed either no or only weak activity compared to <term id="T37" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat T cells</term>.</sentence>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T34"/>
<clue><clueLoc>In EBV-transformed B clones</clueLoc>, the chi B site <clueType>exerted</clueType> the strongest <corefTheme>inducible activity</corefTheme>; the NF-AT binding sites showed either no or only weak activity compared to Jurkat T cells.</clue>
</event>
<event Manner="Low" assertion="non-exist" id="E16">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T36"/>
<clue><clueLoc>In EBV-transformed B clones</clueLoc>, the chi B site exerted the strongest inducible activity; the NF-AT binding sites showed either <clueManner>no or only weak</clueManner> <corefTheme>activity</corefTheme> compared to Jurkat T cells.</clue>
</event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="T12"/>
<cause idref="T36"/>
<clue>In EBV-transformed B clones, the chi B site exerted the strongest inducible activity; the NF-AT binding sites showed either no or only weak <corefTheme>activity</corefTheme> compared <clueLoc>to Jurkat T cells</clueLoc>.</clue>
</event>
<event id="E39">
<type class="Biological_process"/>
<theme idref="A12"/>
<clue>In EBV-<clueType>transformed</clueType> B clones, the chi B site exerted the strongest inducible activity; the NF-AT binding sites showed either no or only weak activity compared to Jurkat T cells.</clue>
</event>
<event id="E46">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="A11"/>
<clue>In EBV-<clueType>transformed</clueType> B clones, the chi B site exerted the strongest inducible activity; the NF-AT binding sites showed either no or only weak activity compared to Jurkat T cells.</clue>
</event>
<sentence id="S7">An <term id="T38" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T39" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term> bearing a defective <term id="T40" lex="NF-chi_B_site" sem="DNA_domain_or_region"><term id="T41" lex="NF-chi_B" sem="Protein_molecule">NF-<term id="T42" lex="chi_B_site" sem="DNA_domain_or_region">chi B</term></term> site</term> was completely inactive in <term id="T43" lex="EBV-transformed_B_cell" sem="Cell_cultured"><term id="A10" sem="Virus">EBV</term>-transformed <term id="T44" lex="B_cell" sem="Cell_natural">B cells</term></term>, while it still had activity in <term id="T45" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat T cells</term>.</sentence>
<event id="E38">
<type class="Biological_process"/>
<theme idref="T44"/>
<clue>An IL-2 promoter bearing a defective NF-chi B site was completely inactive in EBV-<clueType>transformed</clueType> B cells, while it still had activity in Jurkat T cells.</clue>
</event>
<event id="E47">
<type class="Positive_regulation"/>
<theme idref="E38"/>
<cause idref="A10"/>
<clue>An IL-2 promoter bearing a defective NF-chi B site was completely inactive in EBV-<clueType>transformed</clueType> B cells, while it still had activity in Jurkat T cells.</clue>
</event>
<sentence id="S8">In seven <term id="A4" sem="Cell_cultured"><term id="T46" lex="EBV-B_cell_clone" sem="Cell_cultured">EBV-B cell clones</term> or lines</term> differing in their capacity to secrete <term id="T47" lex="IL-2" sem="Protein_molecule">IL-2</term>, the activity of the <term id="T48" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T49" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term> correlated well with the status of <term id="T50" lex="IL-2_secretion" sem="Other"><term id="T51" lex="IL-2" sem="Protein_molecule">IL-2</term> secretion</term>.</sentence>
<event KT="Other" id="E20">
<type class="Localization"/>
<theme idref="T47"/>
<clue><clueLoc>In</clueLoc> seven <clueLoc>EBV-B cell clones</clueLoc> or lines differing in their capacity to <clueType>secrete</clueType> IL-2, the activity of the IL-2 promoter correlated well with the status of IL-2 secretion.</clue>
<comment>TPS: A4</comment></event>
<event KT="Other" id="E19">
<type class="Localization"/>
<theme idref="T47"/>
<clue><clueLoc>In</clueLoc> seven <clueLoc>EBV-B cell</clueLoc> clones or <clueLoc>lines</clueLoc> differing in their capacity to <clueType>secrete</clueType> IL-2, the activity of the IL-2 promoter correlated well with the status of IL-2 secretion.</clue>
<comment>TPS: A4</comment></event>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<clue><clueLoc>In</clueLoc> seven <clueLoc>EBV-B cell clones</clueLoc> or lines differing in their capacity to secrete IL-2, the <clueType>activity</clueType> <linkTheme>of</linkTheme> the IL-2 promoter correlated well with the status of IL-2 secretion.</clue>
</event>
<event KT="Other" id="E43">
<type class="Positive_regulation"/>
<theme idref="T48"/>
<clue><clueLoc>In</clueLoc> seven <clueLoc>EBV-B cell</clueLoc> clones or <clueLoc>lines</clueLoc> differing in their capacity to secrete IL-2, the <clueType>activity</clueType> <linkTheme>of</linkTheme> the IL-2 promoter correlated well with the status of IL-2 secretion.</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Correlation"/>
<theme idref="E18"/>
<theme idref="E22"/>
<clue>In seven EBV-B cell clones or lines differing in their capacity to secrete IL-2, the activity of the IL-2 promoter <clueType><clueKT>correlated</clueKT></clueType> well <clueType>with the status</clueType> <linkTheme>of</linkTheme> IL-2 secretion.</clue>
</event>
<event KT="Other" id="E22">
<type class="Localization"/>
<theme idref="T51"/>
<clue>In seven EBV-B cell clones or lines differing in their capacity to secrete IL-2, the activity of the IL-2 promoter correlated well with the status of IL-2 <clueType>secretion</clueType>.</clue>
</event>
<sentence id="S9">Similarly, a <term id="T52" lex="human_immunodeficiency_virus_promoter" sem="DNA_domain_or_region">human immunodeficiency virus promoter</term>, whose activity is controlled through <term id="T53" lex="chi_B_factor" sem="Protein_family_or_group">chi B factors</term>, was found to be active in the <term id="T54" lex="IL-2_producing_EBV-B_cell" sem="Cell_cultured"><term id="T55" lex="IL-2" sem="Protein_molecule">IL-2</term> producing EBV-<term id="T56" lex="B_cell" sem="Cell_natural">B cells</term></term>, but inactive in the <term id="T57" lex="non-IL-2-producing_cell" sem="Cell_cultured">non-<term id="T58" lex="IL-2" sem="Protein_molecule">IL-2</term>-producing cells</term>.</sentence>
<event KT="Other" id="E23">
<type class="Regulation"/>
<theme idref="T52"/>
<clue>Similarly, a human immunodeficiency virus promoter, whose activity is <clueType>controlled</clueType> through chi B factors, was found to be active in the IL-2 producing EBV-B cells, but inactive in the non-IL-2-producing cells.</clue>
</event>
<event KT="Fact" id="E53">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<cause idref="T53"/>
<clue>Similarly, a human immunodeficiency virus promoter, whose activity is controlled <linkCause>through</linkCause> chi B factors, was found to be active in the IL-2 producing EBV-B cells, but inactive in the non-IL-2-producing cells.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E24">
<type class="Gene_expression"/>
<theme idref="T55"/>
<clue>Similarly, a human immunodeficiency virus promoter, whose activity is controlled through chi B factors, was found to be active in the IL-2 <clueType>producing</clueType> <clueLoc>EBV-B cells</clueLoc>, but inactive in the non-IL-2-producing cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Gene_expression"/>
<theme idref="T58"/>
<clue>Similarly, a human immunodeficiency virus promoter, whose activity is controlled through chi B factors, was found to be active in the IL-2 producing EBV-B cells, but inactive in the <cluePolarity>non</cluePolarity>-IL-2-<clueType>producing</clueType> <clueLoc>cells</clueLoc>.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<clue>Similarly, a human immunodeficiency virus promoter, whose activity is controlled through chi B factors, was <clueKT>found</clueKT> to be <clueType>active</clueType> <clueLoc>in the IL-2 producing EBV-B cells</clueLoc>, but inactive in the non-IL-2-producing cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E27">
<type class="Positive_regulation"/>
<theme idref="E23"/>
<clue>Similarly, a human immunodeficiency virus promoter, whose activity is controlled through chi B factors, was <clueKT>found</clueKT> to be active in the IL-2 producing EBV-B cells, but <clueType><cluePolarity>inactive</cluePolarity></clueType> <clueLoc>in the non-IL-2-producing cells</clueLoc>.</clue>
</event>
<sentence id="S10"><term id="T59" lex="electrophoretic_mobility_shift_assay" sem="Other">Electrophoretic mobility shift assays</term> using <term id="T60" lex="protein_extract" sem="Protein_family_or_group">protein extracts</term> from <term id="T61" lex="EBV-B_cell" sem="Cell_cultured">EBV-<term id="T62" lex="B_cell" sem="Cell_natural">B cells</term></term> and the <term id="T63" lex="IL-2_NF-chi_B_probe" sem="Other"><term id="T64" lex="IL-2" sem="Protein_molecule">IL-2</term> <term id="T65" lex="NF-chi_B" sem="Protein_molecule">NF-chi B</term> probe</term> revealed the constitutive generation of <term id="T66" lex="chi_B_complexes" sem="Protein_complex">chi B complexes</term> in <term id="T67" lex="IL-2-secreting_cell" sem="Cell_cultured"><term id="T68" lex="IL-2" sem="Protein_molecule">IL-2</term>-secreting cells</term> consisting mainly of <term id="T69" lex="heterodimeric_p50/p65_complexe" sem="Protein_complex">heterodimeric p50/p65 complexes</term>.</sentence>
<event KT="Analysis" id="E28">
<type class="Positive_regulation"/>
<theme idref="T66"/>
<clue><clueExperiment>Electrophoretic mobility shift assays using protein extracts from EBV-B cells and the IL-2 NF-chi B probe</clueExperiment> <clueKT>revealed</clueKT> the constitutive <clueType>generation</clueType> <linkTheme>of</linkTheme> chi B complexes <clueLoc>in IL-2-secreting cells</clueLoc> consisting mainly of heterodimeric p50/p65 complexes.</clue>
</event>
<event KT="Other" id="E29">
<type class="Localization"/>
<theme idref="T68"/>
<clue>Electrophoretic mobility shift assays using protein extracts from EBV-B cells and the IL-2 NF-chi B probe revealed the constitutive generation of chi B complexes in IL-2-<clueType>secreting</clueType> <clueLoc>cells</clueLoc> consisting mainly of heterodimeric p50/p65 complexes.</clue>
</event>
<event KT="Analysis" id="E30">
<type class="Positive_regulation"/>
<theme idref="T69"/>
<clue><clueExperiment>Electrophoretic mobility shift assays using protein extracts from EBV-B cells and the IL-2 NF-chi B probe</clueExperiment> <clueKT>revealed</clueKT> the constitutive <clueType>generation</clueType> <linkTheme>of</linkTheme> chi B complexes <clueLoc>in IL-2-secreting cells</clueLoc> consisting mainly of heterodimeric p50/p65 complexes.</clue>
</event>
<sentence id="S11">A weaker <term id="T70" lex="chi_B_complex_formation" sem="Other"><term id="A13" sem="Protein_complex"><term id="T71" lex="chi_B_site" sem="DNA_domain_or_region">chi B</term> complex</term> formation</term> and faster-migrating complexes were detected in <term id="T72" lex="non-IL-2-secreting_cell" sem="Cell_cultured">non-<term id="T73" lex="IL-2" sem="Protein_molecule">IL-2</term>-secreting <term id="A8" sem="Cell_cultured">cells</term></term>.</sentence>
<event Manner="Low" id="E31">
<type class="Positive_regulation"/>
<theme idref="A13"/>
<clue>A <clueManner>weaker</clueManner> chi B complex <clueType>formation</clueType> and faster-migrating complexes were detected <clueLoc>in non-IL-2-secreting cells</clueLoc>.</clue>
</event>
<event Manner="High" id="E32">
<type class="Localization"/>
<theme idref="A13"/>
<clue>A weaker chi B complex formation and <clueManner>faster</clueManner>-<clueType>migrating</clueType> complexes were detected <clueLoc>in non-IL-2-secreting cells</clueLoc>.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E33">
<type class="Localization"/>
<theme idref="T73"/>
<clue>A weaker chi B complex formation and faster-migrating complexes were detected in <cluePolarity>non</cluePolarity>-IL-2-<clueType>secreting</clueType> <clueLoc>cells</clueLoc>.</clue>
</event>
<sentence id="S12">These results demonstrate that the <term id="T74" lex="IL-2_NF-chi_B_site" sem="DNA_domain_or_region"><term id="T75" lex="IL-2" sem="Protein_molecule">IL-2</term> <term id="T76" lex="NF-chi_B" sem="Protein_molecule">NF-chi B</term> site</term> is indispensable for the activity of the <term id="T77" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T78" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term> in <term id="T79" lex="EBV-transformed_B_cell" sem="Cell_cultured"><term id="A9" sem="Virus">EBV</term>-transformed <term id="T80" lex="B_cell" sem="Cell_natural">B cells</term></term>, whereas other <term id="T81" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term> appear to be less important for <term id="T82" lex="IL-2_expression" sem="Other"><term id="T83" lex="IL-2" sem="Protein_molecule">IL-2</term> expression</term> in these cells.</sentence>
<event KT="Analysis" id="E34">
<type class="Positive_regulation"/>
<theme idref="T77"/>
<cause idref="T74"/>
<clue>These results <clueKT>demonstrate</clueKT> that the IL-2 NF-chi B site is <clueType>indispensable for the activity</clueType> <linkTheme>of</linkTheme> the IL-2 promoter <clueLoc>in EBV-transformed B cells</clueLoc>, whereas other transcription factors appear to be less important for IL-2 expression in these cells.</clue>
</event>
<event CL="L2" KT="Analysis" Manner="Low" assertion="non-exist" id="E35" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E37"/>
<cause idref="T81"/>
<clue>These results demonstrate that the IL-2 NF-chi B site is indispensable for the activity of the IL-2 promoter <clueLoc>in EBV-transformed B cells</clueLoc>, whereas other transcription factors <clueKT><clueCL>appear</clueCL></clueKT> to be <clueType><clueManner>less important</clueManner></clueType> <linkTheme>for</linkTheme> IL-2 expression in these cells.</clue>
</event>
<event KT="Other" id="E36">
<type class="Biological_process"/>
<theme idref="T80"/>
<clue>These results demonstrate that the IL-2 NF-chi B site is indispensable for the activity of the IL-2 promoter in EBV-<clueType>transformed</clueType> B cells, whereas other transcription factors appear to be less important for IL-2 expression in these cells.</clue>
</event>
<event KT="Other" id="E48">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="A9"/>
<clue>These results demonstrate that the IL-2 NF-chi B site is indispensable for the activity of the IL-2 promoter in EBV-<clueType>transformed</clueType> B cells, whereas other transcription factors appear to be less important for IL-2 expression in these cells.</clue>
</event>
<event KT="Other" id="E37">
<type class="Gene_expression"/>
<theme idref="T83"/>
<clue>These results demonstrate that the IL-2 NF-chi B site is indispensable for the activity of the IL-2 promoter in EBV-transformed B cells, whereas other transcription factors appear to be less important for IL-2 <clueType>expression</clueType> in these cells.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
